KylePEtzkornMDFACP, CPI
Gastroenterology • Jacksonville, FLAdvanced Endoscopic Interventional, Gastrointestinal Cancer, Hepatology & Liver Transplantation
CEO of Borland-Groover Clinic
Dr. Etzkorn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4800 Belfort Rd
Jacksonville, FL 32256Phone+1 904-398-7205Fax+1 904-396-4047
Education & Training
University of Illinois College of Medicine at ChicagoFellowship, Advanced Endoscopy, 1993 - 1994
University of Texas Health Science Center at HoustonFellowship, Gastroenterology, 1991 - 1993- University of Illinois College of Medicine at ChicagoResidency, Internal Medicine, 1988 - 1990
University of ChicagoInternship, Psychiatry, 1987 - 1988
University of Missouri Kansas City School of MedicineClass of 1987
Certifications & Licensure
FL State Medical License 1996 - 2026
IL State Medical License 1987 - 2014- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2011-2013
- Top Doctors: Florida Castle Connolly, 2000
Publications & Presentations
PubMed
- 62 citationsSofosbuvir-velpatasvir with ribavirin for 24 weeks in hepatitis C virus patients previously treated with a direct-acting antiviral regimen.Edward Gane, Mitchell L. Shiffman, Kyle Etzkorn, Giuseppe Morelli, Catherine A.M. Stedman
Hepatology. 2017-10-01 - 85 citationsSofosbuvir With Velpatasvir in Treatment-Naive Noncirrhotic Patients With Genotype 1 to 6 Hepatitis C Virus Infection: A Randomized TrialGregory T. Everson, William J. Towner, M. Davis, David L. Wyles, Ronald Nahass
Annals of Internal Medicine. 2015-12-01 - 46 citationsEfficacy of Sofosbuvir, Velpatasvir, and GS-9857 in Patients With Hepatitis C Virus Genotype 2, 3, 4, or 6 Infections in an Open-Label, Phase 2 Trial.Edward Gane, Kris V. Kowdley, David Pound, Catherine A.M. Stedman, M. Davis
Gastroenterology. 2016-11-01
Press Mentions
OMNY Health Launches New GI Real-World Data Solutions in Partnership with Leading US Gastroenterology PracticesApril 22nd, 2024- Borland Groover Breaks Ground on St. Johns Surgery CenterOctober 28th, 2020
- OMNY Health Launches New GI Real-World Data Solutions in Partnership with Leading US Gastroenterology PracticesApril 23rd, 2024
Other Languages
- German
External Links
- Borland Groover Clinichttp://Borland-Groover.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
